PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Jun 2017

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2017
Quarter 2 Qtr
Quarterly report for the financial period ended 30 Jun 2017
The figures have not been audited

Attachments

Pharma Q2 2017.pdf
316.3 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2017

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2017
30 Jun 2016
30 Jun 2017
30 Jun 2016
$$'000
$$'000
$$'000
$$'000
1 Revenue
517,967
531,796
1,136,261
1,090,991
2 Profit/(loss) before tax
10,150
21,487
37,927
48,025
3 Profit/(loss) for the period
9,751
15,641
29,009
34,111
4 Profit/(loss) attributable to ordinary equity holders of the parent
9,520
14,995
28,443
33,374
5 Basic earnings/(loss) per share (Subunit)
3.67
5.79
10.97
12.89
6 Proposed/Declared dividend per share (Subunit)
4.00
5.00
8.00
9.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0900
2.0500

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 16 Aug 2017
Category Financial Results
Reference Number FRA-14082017-00025